Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALBOCICLIB for Metastases to bone: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 556 adverse event reports in the FDA FAERS database where PALBOCICLIB was used for Metastases to bone.

Most Reported Side Effects for PALBOCICLIB

Side Effect Reports % Deaths Hosp.
Fatigue 15,190 16.7% 522 1,889
White blood cell count decreased 11,273 12.4% 420 1,505
Neoplasm progression 10,885 12.0% 1,499 1,400
Death 8,410 9.2% 8,384 556
Nausea 8,189 9.0% 346 1,395
Neutropenia 6,423 7.1% 313 759
Alopecia 6,201 6.8% 137 619
Diarrhoea 5,635 6.2% 187 983
Asthenia 3,660 4.0% 320 920
Off label use 3,405 3.7% 353 451
Decreased appetite 3,400 3.7% 238 757
Pain 3,384 3.7% 179 698
Malaise 3,294 3.6% 199 710
Dyspnoea 3,178 3.5% 304 1,116
Vomiting 3,060 3.4% 236 929

Other Indications for PALBOCICLIB

Breast cancer metastatic (18,160) Breast cancer female (17,915) Breast cancer (13,075) Product used for unknown indication (2,475) Neoplasm malignant (1,996) Breast cancer stage iv (1,232) Bone cancer (493) Hormone receptor positive her2 negative breast cancer (386) Invasive ductal breast carcinoma (332) Breast cancer recurrent (318)

Other Drugs Used for Metastases to bone

DENOSUMAB (5,083) ZOLEDRONIC ACID (3,177) RADIUM RA-223 DICHLORIDE (1,501) CABOZANTINIB S-MALATE (514) ENZALUTAMIDE (439) XGEVA (412) RIBOCICLIB (383) LETROZOLE (263) CARBOPLATIN (254) PACLITAXEL (254)

Related Pages

PALBOCICLIB Full Profile All Metastases to bone Drugs PALBOCICLIB Demographics PALBOCICLIB Timeline